文献速递儿童青少年精神

母亲自身抗体相关孤独症(MAR-ASD)风险评估分析:孤独症的一种亚型

Risk assessment analysis for maternal autoantibody-related autism (MAR-ASD): a subtype of autism.
PubMed 文献 · Mol Psychiatry · 2021-01-22

本研究开发并验证了一种血清学检测方法,用于识别针对八种胎儿脑蛋白的母亲自身抗体反应模式,并确定其与孤独症谱系障碍(ASD)结局严重程度的关系。研究使用450名ASD儿童母亲和342名典型发育儿童母亲的血浆,发现几种ASD特异性反应模式,其中CRMP1+GDA、CRMP1+CRMP2和NSE+STIP1模式与ASD显著相关。母亲对CRMP1的自身抗体反应性显著增加儿童ADOS严重度评分较高的几率。

要点

  • MAR-ASD特异性自身抗体模式在ASD组中占18%(训练集)和10%(验证集),而TD组为0%。
  • CRMP1+GDA模式与ASD的OR为31.04(p<0.0001),CRMP1+CRMP2的OR为26.08(p=0.0005),NSE+STIP1的OR为22.82(p=0.0001)。
  • 母亲对CRMP1的自身抗体反应性增加儿童ADOS严重度评分较高的几率(OR 2.3;95% CI: 1.358-3.987,p=0.0021)。

核心结论

  • 母亲自身抗体相关孤独症(MAR-ASD)特异性反应模式可作为孤独症风险的潜在生物标志物,识别高达18%的ASD病例。

研究设计与样本

  • 研究使用450名ASD儿童母亲和342名典型发育儿童母亲的血浆,开发ELISA检测八种胎儿脑蛋白抗原,并确定反应模式与ASD结局严重程度的关系。

主要发现

  • ASD特异性反应模式在训练集中占18%,验证集中占10%,而TD组为0%。
  • CRMP1+GDA模式与ASD显著相关(ASD% = 4.2 vs. TD% = 0,OR 31.04,p < 0.0001)。
  • CRMP1+CRMP2模式与ASD显著相关(ASD% = 3.6 vs. TD% = 0,OR 26.08,p = 0.0005)。
  • NSE+STIP1模式与ASD显著相关(ASD% = 3.1 vs. TD% = 0,OR 22.82,p = 0.0001)。
  • 母亲对CRMP1的自身抗体反应性显著增加儿童ADOS严重度评分较高的几率(OR 2.3;95% CI: 1.358-3.987,p = 0.0021)。

临床怎么用

  • 该血清学检测可用于识别MAR-ASD亚型,为孤独症风险评估提供生物标志物参考。
  • 母亲自身抗体反应模式可能有助于预测儿童孤独症严重程度。

局限性

  • 研究仅基于特定人群,样本量有限,需进一步验证。
  • MAR-ASD特异性模式仅覆盖部分ASD病例,不能解释所有孤独症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The incidence of autism spectrum disorder (ASD) has been rising, however ASD-risk biomarkers remain lacking. We previously identified the presence of maternal autoantibodies to fetal brain proteins specific to ASD, now termed maternal autoantibody-related (MAR) ASD. The current study aimed to create and validate a serological assay to identify ASD-specific maternal autoantibody patterns of reactivity against eight previously identified proteins (CRMP1, CRMP2, GDA, NSE, LDHA, LDHB, STIP1, and YBOX) that are highly expressed in developing brain, and determine the relationship of these reactivity patterns with ASD outcome severity. We used plasma from mothers of children diagnosed with ASD (n = 450) and from typically developing children (TD, n = 342) to develop an ELISA test for each of the protein antigens. We then determined patterns of reactivity a highly significant association with ASD, and discovered several patterns that were ASD-specific (18% in the training set and 10% in the validation set vs. 0% TD). The three main patterns associated with MAR ASD are CRMP1 + GDA (ASD% = 4.2 vs. TD% = 0, OR 31.04, p = <0.0001), CRMP1 + CRMP2 (ASD% = 3.6 vs. TD% = 0, OR 26.08, p = 0.0005) and NSE + STIP1 (ASD% = 3.1 vs. TD% = 0, OR 22.82, p = 0.0001). Additionally, we found that maternal autoantibody reactivity to CRMP1 significantly increases the odds of a child having a higher Autism Diagnostic Observation Schedule (ADOS) severity score (OR 2.3; 95% CI: 1.358-3.987, p = 0.0021). This is the first report that uses machine learning subgroup discovery to identify with 100% accuracy MAR ASD-specific patterns as potential biomarkers of risk for a subset of up to 18% of ASD cases in this study population.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Ramirez-Celis A, Becker M, Nuño M, et al. Risk assessment analysis for maternal autoantibody-related autism (MAR-ASD): a subtype of autism. Mol Psychiatry. 2021. PMID: 33483694. doi:10.1038/s41380-020-00998-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。